Total revenue (estimated): 1.1 trillion JPY (2025)

Industry distribution:

• Pharmacies and drugstores: approx. 85%
• Cosmetics and beauty products: approx. 10%
• Food and beverages: approx. 5%

TOP 3 markets:

1. Japan: approx. 90%
2. China: approx. 5%
3. Southeast Asia: approx. 3%

Tsuruha Holdings Inc. generates the majority of its revenue from the pharmacies and drugstores sector, which is typical for the business model of a drugstore conglomerate. The Japanese market dominates the revenues as Tsuruha has a strong presence with numerous branches domestically. The expansion into international markets, especially in China and Southeast Asia, also contributes to the revenues, but to a significantly lesser extent compared to the domestic market.

Production Sites: No specific proprietary production facilities known

Tsuruha Holdings Inc. is mainly engaged in retail and operates one of the largest drugstore chains in Japan. The company generally does not produce its own products, but sources them from various manufacturers and suppliers. These products include a wide range of health and beauty items that are sold in the stores.

As a retailer, Tsuruha Holdings focuses on distributing products from third-party providers rather than operating its own production facilities. The exact origin of the products depends on the respective suppliers, which can come from both Japan and internationally.

Revenue Growth: 8.5% (2024)
Profit Growth: 6.2% (2024)

Tsuruha Holdings Inc. pursues a growth strategy based on expanding its network of stores and strengthening its online presence. The company plans to further increase the number of physical stores in Japan and other Asian markets to solidify its market presence and attract new customers.

Additionally, Tsuruha is investing in digitalization and expanding its e-commerce business to capitalize on the growing trend of online shopping. By integrating online and offline channels, the company aims to provide a seamless shopping experience and enhance customer loyalty.

Another focus is on diversifying the product offering, especially in the health and beauty products sector, to meet changing consumer preferences. Tsuruha also relies on strategic partnerships and acquisitions to strengthen its market position and leverage synergies.

Main import materials: Pharmaceutical raw materials, cosmetic ingredients, health products

Main import countries: China, India, Germany

Tsuruha Holdings Inc., a leading company in the drugstores and pharmacies sector in Japan, imports a variety of raw materials and components necessary for the production and distribution of their products. The pharmaceutical raw materials and cosmetic ingredients mainly come from China and India, as these countries are significant producers of generic pharmaceutical active ingredients and cosmetic components.

Germany is also an important trading partner, especially for high-quality health products and specialized pharmaceutical components. These imports are crucial to ensure product variety and quality in Tsuruha stores and to offer customers a wide range of health and beauty products.

Market share in Japan: approximately 15% (2024)
Number of stores: over 2,400 (2024)
Revenue growth: 5.8% (2024)

Tsuruha Holdings Inc. is one of the leading providers in the Japanese drugstore market and has secured a significant competitive advantage through a strong presence with over 2,400 stores. The market share of about 15% underscores the company's dominant position in Japan.

Another competitive advantage arises from the wide range of products and the strategic placement of stores, which promote high customer loyalty. The company also benefits from efficient supply chains and a well-established brand image, which has contributed to a stable revenue growth of 5.8% in 2024.

Tsuruha Holdings continuously invests in digital transformation and customer loyalty, further strengthening its competitiveness. Expansion into new markets and adaptation to changing consumer trends are also key factors for long-term success.

Institutional Investor Share: approximately 45% (2025, estimated)

Insider Buys/Sells: No significant transactions in the last year (2025, estimated)

The institutional investor share in Tsuruha Holdings Inc. is around 45%. This demonstrates the confidence of institutional investors in the company, which often indicates stable financial performance and growth potential.

In 2025, there were no significant insider transactions, suggesting that the management and other insiders do not anticipate significant changes in the stock value. This can be interpreted as a sign of stability and confidence in the current company strategy.

Market share of Tsuruha Holdings Inc.: 12% (2025, estimated)

Main competitors and their market share:

1. Welcia Holdings Co., Ltd.: 15%
2. Matsumotokiyoshi Holdings Co., Ltd.: 14%
3. Sundrug Co., Ltd.: 10%
4. Kokumin Co., Ltd.: 8%
5. Sugi Holdings Co., Ltd.: 7%

Tsuruha Holdings Inc. is one of the leading players in the Japanese drugstore market. The 12% market share positions the company as one of the top players, but behind Welcia Holdings and Matsumotokiyoshi Holdings. These two companies have a slight lead in terms of market share.

Moat of Tsuruha Holdings Inc.:

Tsuruha Holdings has a moderate moat, mainly supported by its extensive store presence and strong brand recognition. The company has invested in digitization and customer loyalty in recent years, enhancing its competitiveness.

Compared to competitors, Welcia Holdings has a significant advantage due to its strategic partnerships and stronger presence in urban areas. Matsumotokiyoshi benefits from strong brand loyalty and a wide product range.

Overall, Tsuruha Holdings has a solid, but not insurmountable moat. The competition may have the upper hand in some areas, such as urban presence and strategic alliances. Nevertheless, Tsuruha remains a significant player with potential to increase market share through targeted expansion and innovations.

Revenue Growth: 6.8% (2024) Profit Growth: 5.2% (2024) Market Share in Japan: 12% (2024)

Tsuruha Holdings Inc. recorded a revenue growth of 6.8% in 2024, attributed to solid expansion and a strong market position in Japan. With a market share of 12%, Tsuruha is one of the leading players in the Japanese drugstore market.

The company also achieved a profit growth of 5.2% in the same period. This indicates that Tsuruha is able to effectively manage its costs while improving its margins.

The long-term growth prospects for Tsuruha are positive, especially due to the ongoing aging of the population in Japan, which is expected to lead to increased demand for health and care products. Tsuruha is also investing in digitization and expanding its online offerings, providing additional growth opportunities.

Overall, Tsuruha Holdings Inc. could be an attractive investment opportunity for investors interested in a stable company with growth potential.

Dividend Yield: 2.1% (2025, estimated)
Dividend History: Continuous payout over the last 5 years

Tsuruha Holdings Inc. is known for pursuing a stable dividend policy. The company has consistently distributed dividends in recent years, indicating a reliable payout.

The estimated dividend yield of 2.1% in 2025 shows that Tsuruha Holdings aims to provide its shareholders with a consistent value. This stability in dividend policy is supported by the company's solid financial performance and strong market position.